Search
Search
Breast cancer cells with higher than normal levels of HER2 are called HER2-positive. These cancers tend to grow and spread faster than breast cancers that are ...
#2. Symptoms of HER2-Positive Breast Cancer - WebMD
HER2 -positive breast cancer is when breast cancer cells have a protein receptor called HER2 (human epidermal growth factor receptor 2).
#3. HER2 Status: Tests, Treatments, and More - Breastcancer.org
Breast cancers with HER2 gene amplification or HER2 protein overexpression are called HER2-positive in the pathology report. HER2-positive ...
#4. HER2-Negative vs HER2-Positive: What's the Difference?
If breast cancer cells don't have abnormal levels of HER2 proteins, the breast cancer is considered HER2-negative. Even if ...
#5. HER2-positive breast cancer - PubMed
With survival rates of almost 5 years in women with metastatic HER2-positive breast cancer and 75% of patients achieving a pathological complete ...
#6. Treatment of early HER2-positive breast cancer (Beyond the ...
In the past, tumors with high levels of HER2 (also known as HER2-positive tumors) were associated with an increased risk of both recurrence and ...
#7. Current and Future Management of HER2-Positive Metastatic ...
Advanced breast cancer with overexpression and/or amplification of human epidermal growth factor receptor 2 (HER2) is a clinically aggressive ...
#8. Herceptin (trastuzumab) - NHS
early-stage HER2 positive breast cancer, following surgery and/or radiotherapy and chemotherapy, to reduce the risk of the cancer coming back · advanced HER2 ...
#9. Early HER2-Positive Breast Cancer: Current Treatment and ...
Overexpression of human epidermal growth factor receptor 2 (HER2) occurs in 15–20% of breast cancers and portends an aggressive phenotype and poor patient ...
#10. New Treatments Emerge for Metastatic HER2+ Breast Cancer
Breast cancers that are HER2-positive tend to be aggressive, with the excess HER2 protein on tumor cells fueling the cancer's growth.
#11. Phenotypic changes of HER2-positive breast cancer during ...
The HER2-enriched (HER2-E) subtype within HER2-positive (HER2+) breast cancer is highly addicted to the HER2 pathway. However, ∼20–60% of ...
#12. HER2 Positive vs. HER2 Negative Breast Cancer - Verywell ...
Too much HER2 protein, however, can cause some types of breast cancer to grow and spread. HER2-positive breast cancers have abnormally high ...
#13. HER2-negative breast cancer: What does it mean and more
When a breast cancer is HER2-negative, it means that the cancerous cells do not contain high levels of the protein HER2. There are many treatment options ...
#14. Breast Cancer - Metastatic: Types of Treatment
Everolimus is used with the AI exemestane for ER-positive, HER2-negative metastatic breast cancer that has grown despite treatment with another AI. Side effects ...
#15. HER2 (Breast Cancer) Testing - MedlinePlus
HER2 is a protein found on breast cells. It is involved in normal cell growth. In some cancers, the cells have too much HER2 protein.
#16. Trastuzumab for early-stage, HER2-positive breast cancer
Amplification of the HER2 gene (also known as ERBB2) is present in 10–20% of tumours in patients with early-stage breast cancer and is ...
#17. PIK3CA mutations in HER2-positive breast cancer - Annals of ...
PIK3CA mutations in HER2-positive breast cancer: an ongoing conundrum · The routine use of therapeutic agents that specifically target the human epidermal growth ...
#18. Prognosis and survival for breast cancer
HER2 -positive breast cancer is more aggressive and more likely to spread than HER2-negative breast cancer. They are also more likely to come back after ...
#19. Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive ...
Patients with human epidermal growth factor receptor 2 (HER2)–positive metastatic breast cancer who have disease progression after therapy ...
#20. HER2 Positive Breast Cancer Risk Factors | Moffitt
The exact causes of breast cancers – including HER2 (human epidural growth factor receptor 2) positive breast cancer – are not fully understood.
#21. Management of Early-Stage HER2-Positive Breast Cancer
HER2 -positive breast cancer is highly curable because of the availability of these HER2-targeted therapies, so we treat patients fairly ...
#22. Breast Cancer and HER2 - Medscape Reference
3+: Positive HER2 expression - Uniform intense membrane staining of more than 30% of invasive tumor cells. · 2+: Equivocal for HER2 protein ...
#23. HER2-Positive Breast Cancer | Clinical - Targeted Oncology
Alexandra Higgins, MD, discusses when to use ado-trastuzumab emtansine in patients with HER2-positive breast cancer, and how to address particular adverse ...
#24. 14 Breast Cancer Questions for Your Doctor – Cleveland Clinic
HER2 (which stands for human epidermal growth factor receptor 2) is another type of growth signal receptor (or antenna) which may be present on ...
#25. Treating HER2-Positive and Triple-Negative Breast Cancer
Women diagnosed with HER2-positive breast cancer have cancer driven by the overproduction of a protein called human epidermal growth factor ...
#26. Biomarkers for HER2-positive metastatic breast cancer
Human epidermal growth factor receptor-2 (HER2) is overexpressed in 15–20% of breast cancer (BC) cases, resulting in an aggressive clinical behaviour [1]. The ...
#27. HER2-Positive Breast Cancer | Penn Medicine
Breast cancer identified as HER2-positive tends to grow faster, spread (metastatic breast cancer) and come back (recur). While HER2-positive cancer may be ...
#28. HER2-positive breast cancer, how far away from the cure?
According to previous research data, HER2-positive breast cancer accounts for about 20% to 25% of all breast cancer patients (3-6). Trastuzumab is the first ...
#29. Types of Breast Cancer
This type of cancer is called HER2 positive and makes cells grow in an uncontrolled way. If your cancer is ...
#30. HER2-Positive Metastatic Breast Cancer - Millennium Medical ...
Abstract: Cases of human epidermal growth factor receptor 2 (HER2)–positive breast cancer represent approximately 15% to 20% of all breast cancers.
#31. Implementing antibody-drug conjugates (ADCs) in HER2 ...
Two anti-HER2 ADCs have been approved by the FDA with different indications in HER2-positive breast cancer. Ado-trastuzumab emtansine (T-DM1) ...
#32. HER2-positive breast cancer - Roche
Approximately one in five women diagnosed with breast cancer worldwide will have HER2-positive breast cancer, a particularly aggressive form of the disease.2 ...
#33. HER2 | Breast Cancer Now
Some breast cancer cells have a higher than normal level of a protein called HER2 (human epidermal growth factor receptor 2) on their surface, ...
#34. New targeted drugs show promise in patients with advanced ...
For patients with HER2-positive breast cancer no longer responding to standard therapies, a pair of clinical trials led by investigators at Dana ...
#35. HER2-Positive Breast Cancer: Symptoms, Treatment & Causes
All patients with invasive breast cancer should have their tumor cells tested for HER2. In about 10%-20% of women with breast cancer, the cancer cells test ...
#36. Adjuvant Therapy for HER2-Positive Breast Cancer - JAMA ...
Patients with small, human epidermal growth factor receptor 2 (HER2)–positive breast tumors treated with adjuvant paclitaxel and trastuzumab ...
#37. Genentech Her2 Story
Herceptin is approved for the treatment of early stage breast cancer that is Human Epidermal growth factor Receptor 2-positive (HER2-positive) and has spread ...
#38. HER2 Gene Amplification in ER-positive HER2 ...
Background/Aim: In estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer, standard chemotherapies as well ...
#39. Early and metastatic HER2-positive breast cancer - NICE
Summary of the evidence on subcutaneous trastuzumab for HER2-positive breast cancer to inform local NHS planning and decision-making.
#40. Therapeutic targeting of HER2–CB2R heteromers in ... - PNAS
There is a subtype of breast cancer characterized by the overexpression of the oncogene HER2. Although most patients with this diagnosis benefit ...
#41. Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer ...
Upfront trastuzumab treatment is beneficial to patients with HER2 positive breast cancer. The potential synergistic cardiotoxicity of trastuzumab and ...
#42. Tests on your breast cancer cells
Triple negative breast cancers don't have oestrogen receptors, progesterone receptors or HER2 receptors. Around 15 out of 100 women have this ...
#43. HER2-Targeted Therapies for Early Breast Cancer - Susan G ...
Breast cancer treatment ... For women with HER2-positive early breast cancer, chemotherapy plus trastuzumab cuts the risk of recurrence in half compared to ...
#44. What is HER2 positive breast cancer?
There are many different types of breast cancer. If you're diagnosed with HER2 positive breast cancer, this means your cancer cells have higher than normal ...
#45. Enhertu reduced the risk of disease progression or death by ...
trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer. PUBLISHED 18 September 2021 ...
#46. Treatment Options in HER2-Positive Metastatic Breast Cancer
Sara A. Hurvitz, MD: The treatment of HER2 [human epidermal growth factor receptor 2]-positive metastatic breast cancer has vastly improved ...
#47. Types of breast cancer
Some breast cancers are also identified by whether or not the cancer cells have receptors for hormones or a protein called HER2 (HER2 positive breast ...
#48. Evolving standards of care and new challenges in the ...
The management of human epidermal growth factor receptor (HER2)–positive breast cancer (BC) has rapidly evolved over the last 20 years.
#49. HER2 Positive Breast Cancer | OncoLink
How are HER2 positive breast cancers treated? · There are several targeted therapies available for the treatment of HER2+ breast cancers.
#50. How we treat HER2-positive brain metastases - ESMO Open
Overexpression of the human epidermal growth factor 2 (HER2)/neu glycoprotein receptor in breast cancer is associated with increased risk of ...
#51. Identification of HER2-Positive Metastases in Patients with ...
Approximately 80% of these women have HER2-negative primary malignancies. If 13% of women with metastatic HER2-negative primary breast cancer ...
#52. HER2 Positive Breast Cancer: What's New in Treatment and ...
Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss advances in research and treatment for patients with HER2+ metastatic breast cancer ...
#53. 6 Questions About HR-Positive/HER2-Negative Metastatic ...
“Roughly half of metastatic breast cancers are both HR-positive and HER-2-negative,” says Brufsky. “About 70 percent of the time, this subtype ...
#54. Management of HER2-Positive Breast Cancer - The ASCO Post
MANAGEMENT OF HER2-positive breast cancer changed after the introduction of trastuzumab (Herceptin), the first anti-HER2 therapy to be ...
#55. Risk-based decision-making in the treatment of HER2-positive ...
Treatment of HER2-positive early breast cancer (EBC) continues to evolve with neoadjuvant (pre-operative) and adjuvant (post-operative) ...
#56. Vaccine study for HER2-positive breast cancer moves forward
Trastuzumab works by activating the immune system's B cells, which look for and attack breast tumor cells with HER2 proteins on the surface. The new vaccine ...
#57. An Overview of HER2-positive Breast Cancer - Cure Today
Most HER2-amplified breast cancers will be hormone receptor-positive, meaning sensitive to either estrogen, progesterone, or both. The minority ...
#58. What Is the Real Impact of Estrogen Receptor Status on the ...
A decrease in Ki67 during neoadjuvant treatment is a surrogate for response and prognosis in HER2-negative/ER + early breast cancer, ...
#59. Targeted therapy | Breast Cancer Network Australia
Herceptin (trastuzumab) is the best known of the targeted therapies and is used to treat HER2-positive breast cancer. Herceptin does not work for everyone.
#60. HER2-Positive Breast Cancer
HER2 -positive breast cancers can be more aggressive than other types. The good news is that there are effective treatments for this type of ...
#61. HER2+ Cancer Treatment Option | Herceptin® (trastuzumab)
Herceptin has 2 approved uses in metastatic breast cancer: ... Herceptin alone is approved for the treatment of HER2-positive breast cancer in patients who ...
#62. HER2-positive breast cancer cells expressing elevated ...
HER2 -positive breast cancer (HER2+ BC) is an aggressive subtype with a poor prognosis. Although the antibody trastuzumab, which targets the ...
#63. Understanding HER2 positive Breast Cancer and its Treatment
HER2 + "positive" breast cancers can be treated with precision cancer medicines that target the HER2 receptor. Approximately 20-25% of ...
#64. initial PBS authority application form (PB289) - Services ...
Use this form to apply for initial PBS subsidised treatment with trastuzumab emtansine for early HER2 positive breast cancer.
#65. HER2-positive pure mucinous breast carcinoma: A case report...
Tumors of pure mucinous carcinoma are typically positive for both estrogen receptor (ER) and progesterone receptor (PR), and they do not ...
#66. Breast cancer, HER2-positive | HemOnc.org
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. Lancet.
#67. HER2+ breast cancer: from no hope to good prognosis in 20 ...
HER2 positive (HER2+) breast cancer is an outstanding example of what can be achieved in oncology when you identify the Achilles heel of a ...
#68. FDA approves new treatment option for patients with HER2 ...
HER2 -positive breast cancer is a type of breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), ...
#69. Clinical Challenge: HER2-Positive Breast Cancer ... - Medpage Today
The median age at breast cancer diagnosis is 63, with about 20% of new cases occurring in women older than 75. HER2-positive breast cancer ...
#70. HER2-positive Breast Cancer Epidemiology | Oncology Nurses
HER2 -positive Breast Cancer Epidemiology · Incidence of female breast cancer estimated to be 276,480 new cases. · About 48,530 new cases of carcinoma in situ (CIS) ...
#71. How Do You Tell Whether a Breast Cancer is HER2 Positive ...
More than a decade after the drug trastuzumab (Herceptin) won approval in 1998, scientists still disagree over how to identify breast cancer ...
#72. FDA Approves New Treatment for HER2-positive Breast Cancer
About 15 percent of women diagnosed with breast cancer have tumors characterized by high levels of HER2. For most of these women, a HER2- ...
#73. Updated UK Recommendations for HER2 assessment in ...
1 ,2 Several randomised clinical trials have demonstrated substantial survival benefits in patients with HER2-positive breast cancer treated with anti-HER2 ...
#74. HER2 Positive - My Cancer Genome
... gland neoplasm have the most therapies targeted against HER2 Positive or its related pathways [5]. Ado-Trastuzumab Emtansine +. Breast Carcinoma -.
#75. HER-2 Positive Breast Cancer - News Medical
Approximately 15-25% of breast cancers are linked to a mutation in the HER2 gene and uncontrolled growth of the HER2 receptors and breast cells ...
#76. HER2 Positive Metastatic Breast Cancer Research Update
The treatment landscape for HER2 positive metastatic breast cancer has been rapidly evolving. Since February, the FDA has approved three new ...
#77. Evolution of HER2-Positive Breast Cancer - Oncology Nurse ...
This subtype of breast cancer has been recognized since the early 1980s when the link between HER2 and cancer cells' ability to grow rapidly was ...
#78. Progression of HER2+ mBC - American Journal of Managed ...
Usually in HER2-positive metastatic breast cancer, common places of spread include the liver, lung, bones, lymph nodes, and unfortunately the ...
#79. Pyrotinib plus chemotherapy may benefit patients with ... - Healio
... among patients with pretreated HER2-positive metastatic breast cancer, according to study results presented at San Antonio Breast Cancer ...
#80. HR-positive, HER2-positive breast cancer size could guide ...
Hormone receptor-positive, HER2-positive breast cancers less than 10 mm in size have a heterogeneous response to adjuvant chemoendocrine ...
#81. Management of HER2-positive breast cancer
HER2 -positive breast cancers constitute 25-30% of breast cancers in women. These cancers have a different natural history, clinical course, ...
#82. Pyrotinib, Capecitabine Combination Therapy Improves ...
“Patients with metastatic HER2-positive breast cancer are typically treated with the HER2-targeted therapies trastuzumab (Herceptin) and ...
#83. Profiling and targeting HER2-positive breast cancer using ...
Profiling and targeting HER2-positive breast cancer using trastuzumab emtansine Saeed Sadeghi, Olga Olevsky, Sara A Hurvitz Division of ...
#84. What Is HER-2-Positive Breast Cancer? | Patient Advice
Lehman says about one in five breast cancers test positive for HER-2. These categories aren't mutually exclusive; some tumors can express both ...
#85. Distinguishing HER2-Negative From HER2-Low Breast Cancer
Approximately one-half of breast cancers classified as human epidermal growth factor receptor 2 (HER2)-negative show low HER2 expression ...
#86. HER2 Positive Breast Cancer
“HER2-Positive” breast cancers are fast growing tumors that more frequently spread beyond the breast to other parts of the body. Because of this, they are a ...
#87. All About ER Positive, HER2 Negative Breast Cancer
In addition to hormone receptors, some breast cancers have high levels of a growth-promoting protein called HER2/neu. If a tumor has this ...
#88. Breast cancer - Wikipedia
Untreated, HER2+ breast cancers are generally more aggressive than HER2- breast cancers, but HER2+ cancer cells respond to drugs such as the monoclonal antibody ...
#89. Seagen Announces Updated Results from Pivotal ... - BioSpace
Seagen Announces Updated Results from Pivotal HER2CLIMB Trial Evaluating TUKYSA® (tucatinib) in Patients with HER2-Positive Breast Cancer ...
#90. Zanidatamab Data Presented at the San Antonio Breast ...
The data presented at SABCS are from a clinical study of 24 patients with heavily pretreated HER2-positive metastatic breast cancer who ...
#91. SABCS Clinicogenomic Study Sheds Light on HER2-Targeted ...
Genomic sequencing on 733 HER2-positive advanced breast cancer patients revealed mechanisms of anti-HER2 treatment resistance and potential ...
#92. Seagen Announces Updated Results from Pivotal ...
Seagen Announces Updated Results from Pivotal Trial Evaluating TUKYSA® (tucatinib) in Patients with HER2-Positive Breast Cancer with Brain ...
#93. ENHERTU® (fam-trastuzumab deruxtecan-nxki) Additional ...
... (T-DM1) in patients with HER2 positive unresectable and/or metastatic breast cancer previously treated with trastuzumab and a taxane.
#94. What Is HER2-Positive Breast Cancer? - HealthiNation
In this video, hematologist and oncologist Amy Tiersten, MD, explains what it means to have HER2-positive breast cancer, as well as the ...
#95. 5 Things Friday: Questions to Ask About Your Breast Cancer
About 25 percent of breast cancers are HER2-positive. HER2-positive cancers are a mix of good and bad news. The bad news is the tumors tend ...
breast cancer her2-positive 在 HER2 Positive Breast Cancer: What's New in Treatment and ... 的推薦與評價
Heather Parsons, MD, MPH, and Ian Krop, MD, PhD, discuss advances in research and treatment for patients with HER2+ metastatic breast cancer ... ... <看更多>